Covalon Financial Statements From 2010 to 2024
| CVALF Stock | USD 2.53 0.14 5.24% |
Check Covalon Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Covalon Technologies' main balance sheet or income statement drivers, such as , as well as many indicators such as . Covalon financial statements analysis is a perfect complement when working with Covalon Technologies Valuation or Volatility modules.
Covalon |
Covalon Technologies OTC Stock Operating Margin Analysis
Covalon Technologies' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Covalon Technologies Operating Margin | (0.50) % |
Most of Covalon Technologies' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Covalon Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Covalon Technologies has an Operating Margin of -0.5038%. This is 98.56% lower than that of the Biotechnology sector and 99.55% lower than that of the Health Care industry. The operating margin for all United States stocks is 90.86% lower than that of the firm.
Covalon Technologies Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Covalon Technologies's current stock value. Our valuation model uses many indicators to compare Covalon Technologies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Covalon Technologies competition to find correlations between indicators driving Covalon Technologies's intrinsic value. More Info.Covalon Technologies is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Covalon Technologies' earnings, one of the primary drivers of an investment's value.About Covalon Technologies Financial Statements
Covalon Technologies stakeholders use historical fundamental indicators, such as Covalon Technologies' revenue or net income, to determine how well the company is positioned to perform in the future. Although Covalon Technologies investors may analyze each financial statement separately, they are all interrelated. For example, changes in Covalon Technologies' assets and liabilities are reflected in the revenues and expenses on Covalon Technologies' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Covalon Technologies. Please read more on our technical analysis and fundamental analysis pages.
Covalon Technologies Ltd. researches, develops, manufactures, commercializes, and licenses medical technologies and products in the United States, Canada, Europe, the Middle East, Asia, Latin America, and internationally. It serves hospitals, wound care centers, burn centers, extendedalternate care and acute care facilities, home health care agencies, and physicians offices. Covalon Tech operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in Covalon OTC Stock
Covalon Technologies financial ratios help investors to determine whether Covalon OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Covalon with respect to the benefits of owning Covalon Technologies security.